Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$38.20 USD
-0.95 (-2.43%)
Updated Sep 29, 2023 04:00 PM ET
After-Market: $38.21 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2023
Time: -- |
9/2023 | $0.74 | 0.00% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.63 per share. This reflects a positive earnings surprise of 17.46%. Look out for HALO's next earnings release expected on November 14, 2023. For the next earning release, we expect the company to report earnings of $0.74 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for HALO
Halozyme Therapeutics (HALO) Down 3.8% Since Last Earnings Report: Can It Rebound?
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services